RNA-seq Results

Results indicating the target gene (MIR503 ) expression regulated by m6A regulator (METTL3 )

2C60: Breast cancer

In total 1 results
Result 1 indicating the MIR503 expression regulated by METTL3
Cell Line	MDA-MB-231	CVCL_0062
Condition	Breast cancer	Homo sapiens
Treatment: METTL3 knockdown MDA-MB-231 cells Control: MDA-MB-231 cells		GSE70061
Regulation		logFC: 1.48E+00 p-value: 8.87E-04

Cite M6AREG

S. P. Liu, L. Chen, Y. T. Zhang, Y. Zhou, Y. He, Z. Chen, S. S. Qi, J. Y. Zhu, X. D. Chen, H. Zhang, Y. C. Luo, Y. Q. Qiu, L. Tao*, F. Zhu*. M6AREG: m6A-centered regulation of disease development and drug response. Nucleic Acids Research. 2022 Sep 22;gkac801. PMID: 36134713

Correspondence

Prof. Feng ZHU

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Prof. Shuiping Liu

School of Pharmacy, Hangzhou Normal University, Hangzhou, China

RNA-seq Results

Cite M6AREG

Correspondence

Prof. Feng ZHU

Prof. Shuiping Liu

Visitor Map